Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
16,348,386
-
Share change
-
-4,310,261
-
Total reported value
-
$162,794,964
-
Put/Call ratio
-
75%
-
Price per share
-
$9.97
-
Number of holders
-
80
-
Value change
-
-$42,752,966
-
Number of buys
-
43
-
Number of sells
-
34
Institutional Holders of REPROS THERAPEUTICS INC - COM NEW (RPRX) as of Q4 2014
As of 31 Dec 2014,
REPROS THERAPEUTICS INC - COM NEW (RPRX) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,348,386 shares.
The largest 10 holders included
FMR LLC, BAKER BROS. ADVISORS LP, Sarissa Capital Management LP, BlackRock Institutional Trust Company, N.A., SENZAR ASSET MANAGEMENT, LLC, CQS Cayman LP, BlackRock Fund Advisors, VANGUARD GROUP INC, GENERAL AMERICAN INVESTORS CO INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.